Christine Ng

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Patient-derived organoids for prediction of treatment response in oesophageal adenocarcinoma.

Patient-derived organoids for prediction of treatment response in oesophageal adenocarcinoma.

Journal: The British journal of surgery

Published: September 07, 2023

Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor.

Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor.

Journal: Scientific reports

Published: December 17, 2019

Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy.

Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 17, 2019

Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.

Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 05, 2019

Synergy of WEE1 and mTOR Inhibition in Mutant KRAS-Driven Lung Cancers.

Synergy of WEE1 and mTOR Inhibition in Mutant KRAS-Driven Lung Cancers.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 17, 2017

Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts.

Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts.

Journal: Oncotarget

Published: April 12, 2017

An Anaplastic Lymphoma Kinase Immunohistochemistry-Negative but Fluorescence In Situ Hybridization-Positive Lung Adenocarcinoma Is Resistant to Crizotinib.

An Anaplastic Lymphoma Kinase Immunohistochemistry-Negative but Fluorescence In Situ Hybridization-Positive Lung Adenocarcinoma Is Resistant to Crizotinib.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: July 05, 2016

Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.

Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: July 23, 2015

Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.

Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 01, 2015

Showing 1-9 of 9

Last Updated: 09/26/2026